Augmentation of histone deacetylase 3 (HDAC3) epigenetic signature at the interface of proinflammation and insulin resistance in patients with type 2 diabetes

被引：0
|
作者：
Chandrakumar Sathishkumar
Paramasivam Prabu
Mahalingam Balakumar
Raji Lenin
Durai Prabhu
Ranjith Mohan Anjana
Viswanathan Mohan
Muthuswamy Balasubramanyam
机构：
[1] Madras Diabetes Research Foundation and Dr. Mohan’s Diabetes Specialties Centre,Department of Cell and Molecular Biology and Dr. Rema Mohan High
来源：
Clinical Epigenetics | 2016年 / 8卷
关键词：
HDAC3; Inflammation; Insulin resistance; Type 2 diabetes; Epigenetics; Sirt1; Histone modification;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Activation of the growth-differentiation factor 11 gene by the histone deacetylase (HDAC) inhibitor trichostatin A and repression by HDAC3
    Zhang, XH
    Wharton, W
    Yuan, ZG
    Tsai, SC
    Olashaw, N
    Seto, E
    MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (12) : 5106 - 5118
  • [22] Emerin regulates chromatin architecture and gene expression during myogenic differentiation in cooperation with Histone Deacetylase 3 (HDAC3).
    Demmerle, J.
    Koch, A.
    Lee, J.
    Holaska, J.
    MOLECULAR BIOLOGY OF THE CELL, 2012, 23
  • [23] Inhibition of Histone Deacetylase 3 (HDAC3) Mediates Ischemic Preconditioning and Protects Cortical Neurons against Ischemia in Rats
    Yang, Xiaoyu
    Wu, Qimei
    Zhang, Lei
    Feng, Linyin
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2016, 9
  • [24] HDAC3 as a Molecular Chaperone for Shuttling Phosphorylated TR2 to PML: A Novel Deacetylase Activity-Independent Function of HDAC3
    Gupta, Pawan
    Ho, Ping-Chih
    Ha, Sung Gil
    Lin, Yi-Wei
    Wei, Li-Na
    PLOS ONE, 2009, 4 (02):
  • [25] Nuclear receptor co-repressors are required for the histone-deacetylase activity of HDAC3 in vivo
    You, Seo-Hee
    Lim, Hee-Woong
    Sun, Zheng
    Broache, Molly
    Won, Kyoung-Jae
    Lazar, Mitchell A.
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2013, 20 (02) : 182 - 187
  • [26] Nuclear receptor co-repressors are required for the histone-deacetylase activity of HDAC3 in vivo
    Seo-Hee You
    Hee-Woong Lim
    Zheng Sun
    Molly Broache
    Kyoung-Jae Won
    Mitchell A Lazar
    Nature Structural & Molecular Biology, 2013, 20 : 182 - 187
  • [27] The histone deacetylase HDAC3 is essential for Purkinje cell function, potentially complicating the use of HDAC inhibitors in SCA1
    Venkatraman, Anand
    Hu, Yuan-Shih
    Didonna, Alessandro
    Cvetanovic, Marija
    Krbanjevic, Aleksandar
    Bilesimo, Patrice
    Opal, Puneet
    HUMAN MOLECULAR GENETICS, 2014, 23 (14) : 3733 - 3745
  • [28] Amino Acid Deprivation Increases Lipid Accumulation in HepG2 Hepatoma Cells through Repression of Histone Deacetylase 3 (HDAC3)
    Wang, Huan
    Hess, Kathryn
    Guetterman, Heather
    Chen, Hong
    Pan, Yuan-Xiang
    FASEB JOURNAL, 2015, 29
  • [29] Isoform-selective inhibitor of histone deacetylase 3 (HDAC3) limits pancreatic islet infiltration and protects female nonobese diabetic mice from diabetes
    Dirice, Ercument
    Ng, Raymond W. S.
    Martinez, Rachael
    Hu, Jiang
    Wagner, Florence F.
    Holson, Edward B.
    Wagner, Bridget K.
    Kulkarni, Rohit N.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (43) : 17598 - 17608
  • [30] Suppression of histone deacetylase 3 (HDAC3) enhances apoptosis induced by paclitaxel in human maxillary cancer cells in vitro and in vivo
    Narita, Norihiko
    Fujieda, Shigeharu
    Kimura, Yuichi
    Ito, Yumi
    Imoto, Yoshimasa
    Ogi, Kazuhiro
    Takahashi, Noboru
    Tanaka, Takeshi
    Tsuzuki, Hideaki
    Yamada, Takechiyo
    Matsumoto, Hideki
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 396 (02) : 310 - 316
12345